nitazoxanide has been researched along with mizoribine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, X; Cui, Z; Dong, H; Du, D; Guo, Y; Hu, G; Huang, H; Li, D; Li, G; Shao, J; Teng, Y; Wang, K; Xie, Y; Xingmeng, F; Zhang, Q; Zhang, S; Zhang, Y; Zhao, S; Zhao, Y | 1 |
2 other study(ies) available for nitazoxanide and mizoribine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro.
Topics: Animals; Antiviral Agents; Caliciviridae Infections; Calicivirus, Feline; Cat Diseases; Cats; Cell Line; Drug Synergism; Female; Lung; Nitro Compounds; Ribonucleosides; Thiazoles; Trachea; Viral Load; Virus Shedding | 2020 |